Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Tuberculosis

  Free Subscription


Articles published in J Infect

Retrieve available abstracts of 91 articles:
HTML format



Single Articles


    May 2021
  1. DILLARD LK, Martinez RX, Perez LL, Fullerton AM, et al
    Prevalence of aminoglycoside-induced hearing loss in drug-resistant tuberculosis patients: A systematic review: Ototoxic hearing loss in drug-resistant tuberculosis.
    J Infect. 2021 May 17. pii: S0163-4453(21)00252.
    PubMed     Abstract available


  2. SAM IK, Chen YY, Ma J, Li SY, et al
    TB-QUICK: CRISPR-Cas12b-assisted rapid and sensitive detection of Mycobacterium tuberculosis.
    J Infect. 2021 May 2. pii: S0163-4453(21)00219.
    PubMed     Abstract available


    February 2021
  3. LIU Q, Fang X, Chen X, Dai X, et al
    Letter to the editor: Application of the Xpert MTB/RIF technology in the diagnosis and treatment of osteoarticular tuberculosis.
    J Infect. 2021 Feb 20. pii: S0163-4453(21)00092.
    PubMed    


  4. WANG G, Jiang G, Jing W, Zong Z, et al
    Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: a subsequent study of a national survey.
    J Infect. 2021 Feb 5. pii: S0163-4453(21)00055.
    PubMed     Abstract available


  5. PATTERSON B, Abbara A, Collin S, Henderson M, et al
    Predicting drug-induced liver injury from anti-tuberculous medications by early monitoring of liver tests.
    J Infect. 2021;82:240-244.
    PubMed     Abstract available


    January 2021
  6. LOGAN C, Mullender C, Mirfenderesky M, Feasey N, et al
    Presentations and outcomes of central nervous system TB in a UK cohort: The high burden of neurological morbidity.
    J Infect. 2021;82:90-97.
    PubMed     Abstract available


  7. AHN CS, Shin JW, Kim JG, Lee WY, et al
    Spectrum of pleuropulmonary paragonimiasis: An analysis of 685 cases diagnosed over 22 years.
    J Infect. 2021;82:150-158.
    PubMed     Abstract available


  8. HEAD IM, Lazarus R
    Use of Xpert MTB/RIF in a low prevalence setting in the Southwest of England.
    J Infect. 2021;82:159-198.
    PubMed    


    December 2020
  9. IZZARD A, Wilders S, Smith C, Wickers M, et al
    Improved treatment completion for Tuberculosis patients: the case for a dedicated social care team.
    J Infect. 2020 Dec 23. pii: S0163-4453(20)30780.
    PubMed     Abstract available


  10. MARINE E, Loic H, Christelle GC, Pierre-Louis N, et al
    Improving tuberculosis management in prisons: impact of a rapid molecular point-of-care test.
    J Infect. 2020 Dec 4. pii: S0163-4453(20)30764.
    PubMed     Abstract available


  11. ADANKWAH E, Nausch N, Minadzi D, Abass MK, et al
    Interleukin-6 and Mycobacterium tuberculosis dormancy antigens improve diagnosis of tuberculosis.
    J Infect. 2020 Dec 2. pii: S0163-4453(20)30729.
    PubMed     Abstract available


  12. LIU XH, Xia L, Song B, Wang H, et al
    Stool-based Xpert MTB/RIF Ultra Assay as a tool for detecting pulmonary tuberculosis in children with abnormal chest imaging: a prospective cohort study.
    J Infect. 2020 Dec 1. pii: S0163-4453(20)30727.
    PubMed     Abstract available


    November 2020
  13. VAN ZYL CW, Loots DT, Solomons R, van Reenen M, et al
    Metabolic characterization of tuberculous meningitis in a South African paediatric population using (1)H NMR metabolomics.
    J Infect. 2020;81:743-752.
    PubMed     Abstract available


    September 2020
  14. SUDBURY EL, Clifford V, Messina NL, Song R, et al
    Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review.
    J Infect. 2020 Sep 29. pii: S0163-4453(20)30631.
    PubMed     Abstract available


    August 2020
  15. SHI CL, Han P, Tang PJ, Chen MM, et al
    Clinical Metagenomic Sequencing for etiological diagnosis in pulmonary tuberculosis suspects.
    J Infect. 2020 Aug 5. pii: S0163-4453(20)30537.
    PubMed     Abstract available


  16. CAPOCCI SJ, Sewell J, Smith C, Cropley I, et al
    Cost effectiveness of testing HIV infected individuals for TB in a low TB/HIV setting.
    J Infect. 2020;81:289-296.
    PubMed     Abstract available


    July 2020
  17. KOMIYA K, Yamasue M, Takahashi O, Hiramatsu K, et al
    The COVID-19 pandemic and the true incidence of tuberculosis in Japan.
    J Infect. 2020 Jul 7. pii: S0163-4453(20)30462.
    PubMed    


    June 2020
  18. KIM H, Kim SH, Jung JH, Kim MJ, et al
    The usefulness of quantitative interferon-gamma releasing assay response for predicting active tuberculosis in kidney transplant recipients: a quasi-experimental study.
    J Infect. 2020 Jun 28. pii: S0163-4453(20)30452.
    PubMed     Abstract available


  19. MCGUIRE E, Rajagopal S, Vaikanthanathan T, Krutikov M, et al
    Extraspinal Articular Tuberculosis: an 11-year Retrospective Study of Demographic Features and Clinical Outcomes in East London.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30422.
    PubMed     Abstract available


  20. LAI CC, Yu WL
    The COVID-19 Pandemic and Tuberculosis in Taiwan.
    J Infect. 2020 Jun 10. pii: S0163-4453(20)30397.
    PubMed    


    May 2020
  21. ZHOU X, Zhang L, Lie L, Zhang Z, et al
    MxA suppresses TAK1-IKKalpha/beta-NF-kappaB mediated inflammatory cytokine production to facilitate Mycobacterium tuberculosis infection.
    J Infect. 2020 May 20. pii: S0163-4453(20)30286.
    PubMed     Abstract available


    April 2020
  22. LUO Y, Tang G, Lin Q, Mao L, et al
    Combination of mean spot sizes of ESAT-6 spot-forming cells and modified tuberculosis-specific antigen/phytohemagglutinin ratio of T-SPOT.TB assay in distinguishing between active tuberculosis and latent tuberculosis infection.
    J Infect. 2020 Apr 30. pii: S0163-4453(20)30264.
    PubMed     Abstract available


  23. ESTEVEZ O, Anibarro L, Garet E, Martinez A, et al
    Multi-parameter flow cytometry immunophenotyping distinguishes different stages of tuberculosis infection.
    J Infect. 2020 Apr 21. pii: S0163-4453(20)30218.
    PubMed     Abstract available


  24. HO J, Bokil NJ, Nguyen PTB, Nguyen TA, et al
    A Transcriptional Blood Signature Distinguishes Early Tuberculosis Disease from Latent Tuberculosis Infection and Uninfected Individuals in a Vietnamese Cohort.
    J Infect. 2020 Apr 21. pii: S0163-4453(20)30221.
    PubMed     Abstract available


    March 2020
  25. HU Y, Wen Z, Liu S, Cai Y, et al
    Ibrutinib Suppresses Intracellular Mycobacterium Tuberculosis Growth by Inducing Macrophage Autophagy.
    J Infect. 2020 Mar 11. pii: S0163-4453(20)30115.
    PubMed     Abstract available


    February 2020
  26. PETRUCCIOLI E, Chiacchio T, Navarra A, Vanini V, et al
    Effect of HIV-infection on QuantiFERON-Plus accuracy in patients with active tuberculosis and latent infection: QFT-Plus in HIV infected individuals.
    J Infect. 2020 Feb 22. pii: S0163-4453(20)30093.
    PubMed     Abstract available


  27. SUZUKAWA M, Takeda K, Akashi S, Asari I, et al
    Evaluation of cytokine levels using QuantiFERON-TB Gold Plus in patients with active tuberculosis.
    J Infect. 2020 Feb 22. pii: S0163-4453(20)30092.
    PubMed     Abstract available


    January 2020
  28. PERETOKINA I, Krylova LY, Antonova OV, Kholina MS, et al
    Reduced susceptibility and resistance to bedaquiline in clinical M. tuberculosis isolates.
    J Infect. 2020 Jan 22. pii: S0163-4453(20)30031.
    PubMed     Abstract available


  29. ZHOU Y, Anthony R, Wang S, Ou X, et al
    The epidemic of multidrug resistant tuberculosis in China in historical and phylogenetic perspectives.
    J Infect. 2020 Jan 20. pii: S0163-4453(20)30022.
    PubMed     Abstract available


  30. CAMPRUBI D, Gomila A, Grijota-Camino MD, Soldevila L, et al
    Infectiousness of patients with smear-negative pulmonary tuberculosis, assessed by Real-time Polymerase Chain Reaction, Xpert(R)MTB/RIF.
    J Infect. 2020 Jan 16. pii: S0163-4453(20)30026.
    PubMed     Abstract available


    October 2019
  31. SEKYERE JO, Reta MA, Maningi NE, Fourie PB, et al
    Molecular Epidemiology, Diagnostics and Mechanisms of Antibiotic Resistance in Mycobacterium tuberculosis complex in Africa: A Systematic Review of Current Reports.
    J Infect. 2019 Oct 16. pii: S0163-4453(19)30316.
    PubMed     Abstract available


  32. KARMAKAR M, Trauer JM, Ascher DB, Denholm JT, et al
    Hyper transmission of Beijing lineage Mycobacterium tuberculosis: Systematic review and Meta-analysis.
    J Infect. 2019 Oct 1. pii: S0163-4453(19)30287.
    PubMed     Abstract available


    September 2019
  33. MANALAN K, Green N, Arnold A, Cooke GS, et al
    A cost comparison of amikacin therapy with bedaquiline, for drug-resistant tuberculosis in the UK.
    J Infect. 2019 Sep 21. pii: S0163-4453(19)30277.
    PubMed     Abstract available


    August 2019
  34. SOTGIU G, Saderi L, Petruccioli E, Aliberti S, et al
    QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis.
    J Infect. 2019 Aug 29. pii: S0163-4453(19)30258.
    PubMed     Abstract available


  35. LIU Z, Dong H, Wu B, Zhang M, et al
    Is rifampin resistance a reliable predictive marker of multidrug-resistant tuberculosis in China: A meta-analysis of findings.
    J Infect. 2019 Aug 7. pii: S0163-4453(19)30243.
    PubMed     Abstract available


    July 2019
  36. MANNGO PM, Gutschmidt A, Snyders CI, Mutavhatsindi H, et al
    Prospective evaluation of host biomarkers other than interferon gamma in QuantiFERON Plus supernatants as candidates for the diagnosis of tuberculosis in symptomatic individuals.
    J Infect. 2019 Jul 15. pii: S0163-4453(19)30217.
    PubMed     Abstract available


    June 2019
  37. SUN Q, Wang S, Dong W, Jiang G, et al
    Diagnostic value of Xpert MTB/RIF Ultra for osteoarticular tuberculosis.
    J Infect. 2019 Jun 14. pii: S0163-4453(19)30186.
    PubMed     Abstract available


    May 2019
  38. ZHANG M, He JQ
    Is the analysis sufficient? Letter to the Editor concerning the study of Prof. Wang titled "Xpert MTB/RIF Ultra improved the diagnosis of paucibacillary tuberculosis: A prospective cohort study".
    J Infect. 2019 May 28. pii: S0163-4453(19)30164.
    PubMed    


  39. XU P, Tang P, Song H, Zhao J, et al
    The Incremental Value of Bronchoalveolar Lavage for the Diagnosis of Pulmonary Tuberculosis in a High-Burden Urban Setting.
    J Infect. 2019 May 14. pii: S0163-4453(19)30153.
    PubMed     Abstract available


    April 2019
  40. CHIACCHIO T, Petruccioli E, Vanini V, Cuzzi G, et al
    Characterization of QuantiFERON-TB-Plus results in latent tuberculosis infected patients with or without immune-mediated inflammatory diseases.
    J Infect. 2019 Apr 11. pii: S0163-4453(19)30122.
    PubMed     Abstract available


  41. CAO Y, Yu C, Wu Y
    Incidence rate of depression as an adverse effect of multidrug-resistant tuberculosis treatment.
    J Infect. 2019 Apr 9. pii: S0163-4453(19)30113.
    PubMed    


    March 2019
  42. MAHOMED S, Padayatchi N, Singh J, Naidoo K, et al
    Precision Medicine in Resistant Tuberculosis: Treat the correct patient, at the correct time, with the correct drug.
    J Infect. 2019 Mar 5. pii: S0163-4453(19)30075.
    PubMed     Abstract available


    February 2019
  43. WANG G, Wang S, Jiang G, Yang X, et al
    Xpert MTB/RIF Ultra improved the diagnosis of paucibacillary tuberculosis: a prospective cohort study.
    J Infect. 2019 Feb 20. pii: S0163-4453(19)30059.
    PubMed     Abstract available


    January 2019
  44. ZHANG H, Xin H, Wang D, Pan S, et al
    Serial Testing of Mycobacterium Tuberculosis Infection in Chinese Village Doctors by QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold In-Tube and T-SPOT.TB.
    J Infect. 2019 Jan 30. pii: S0163-4453(19)30030.
    PubMed     Abstract available


  45. LEE MR, Chang CH, Chang LY, Chuang YC, et al
    CD8 response measured by QuantiFERON-TB Gold Plus and tuberculosis disease status.
    J Infect. 2019 Jan 29. pii: S0163-4453(19)30028.
    PubMed     Abstract available


  46. HAMBLION EL, Burkitt A, Lalor MK, Anderson LF, et al
    Public Health Outcome of Tuberculosis Cluster Investigations, England 2010-2013.
    J Infect. 2019 Jan 14. pii: S0163-4453(19)30004.
    PubMed     Abstract available


    December 2018
  47. ZHAO HM, Du R, Li CL, Ji P, et al
    Differential T cell responses against DosR-associated antigen Rv2028c in BCG-vaccinated populations with tuberculosis infection.
    J Infect. 2018 Dec 5. pii: S0163-4453(18)30354.
    PubMed     Abstract available


  48. LUO J, Zhang M, Yan B, Li F, et al
    Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating among Mycobacterium tuberculosis infection.
    J Infect. 2018 Dec 5. pii: S0163-4453(18)30355.
    PubMed     Abstract available


    October 2018
  49. PRADIPTA IS, Forsman LD, Bruchfeld J, Hak E, et al
    Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis.
    J Infect. 2018 Oct 16. pii: S0163-4453(18)30307.
    PubMed     Abstract available


    September 2018
  50. SALI M, Buonsenso D, D'Alfonso P, De Maio F, et al
    Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children.
    J Infect. 2018 Sep 26. pii: S0163-4453(18)30284.
    PubMed     Abstract available


    August 2018
  51. UHEL F, Corvaisier G, Poinsignon Y, Chirouze C, et al
    Mycobacterium tuberculosis prosthetic joint infections: a case series and literature review.
    J Infect. 2018 Aug 20. pii: S0163-4453(18)30253.
    PubMed     Abstract available


  52. HU Y, Yang Q, Dong J, Sun L, et al
    Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs.
    J Infect. 2018 Aug 11. pii: S0163-4453(18)30251.
    PubMed     Abstract available


  53. BORISOV SE, D'Ambrosio L, Centis R, Tiberi S, et al
    Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline -containing regimens and undergoing adjunctive surgery.
    J Infect. 2018 Aug 7. pii: S0163-4453(18)30246.
    PubMed     Abstract available


    July 2018
  54. ALENE KA, Clements ACA, McBryde ES, Jaramillo E, et al
    Mental health disorders, social stressors, and health-related quality of life in patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis.
    J Infect. 2018 Jul 20. pii: S0163-4453(18)30221.
    PubMed     Abstract available


  55. SABI I, Rachow A, Mapamba D, Clowes P, et al
    Xpert MTB/RIF Ultra assay for the diagnosis of pulmonary tuberculosis in children: a multicentre comparative accuracy study.
    J Infect. 2018 Jul 20. pii: S0163-4453(18)30214.
    PubMed     Abstract available


  56. KOWADA A
    Interferon-gamma release assay for tuberculosis screening of solid-organ transplant recipients is cost-effective.
    J Infect. 2018 Jul 12. pii: S0163-4453(18)30215.
    PubMed     Abstract available


    June 2018
  57. GAO Y, Zhang Z, Deng J, Mansjo M, et al
    Multi-center evaluation of GenoType MTBDRsl line probe assay for rapid detection of pre-XDR and XDR Mycobacterium tuberculosis in China.
    J Infect. 2018 Jun 30. pii: S0163-4453(18)30192.
    PubMed     Abstract available


  58. TO KW, Kam KM, Chan DPC, Yip WH, et al
    Application of GeneXpert on bronchoalveolar lavage samples in the clinical management of patients suspicious of tuberculosis in an intermediate-burden setting.
    J Infect. 2018 Jun 28. pii: S0163-4453(18)30189.
    PubMed     Abstract available


  59. MORAN E, Baharani J, Dedicoat M, Robinson E, et al
    Renal failure and active tuberculosis in a high incidence UK city.
    J Infect. 2018 Jun 18. pii: S0163-4453(18)30179.
    PubMed     Abstract available


    May 2018
  60. PT P, B M, Fgj C
    BCG vaccination protects against infection with Mycobacterium tuberculosis ascertained by tuberculin skin testing.
    J Infect. 2018 May 17. pii: S0163-4453(18)30127.
    PubMed     Abstract available


  61. ANURADHA R, Munisankar S, Bhootra Y, Kumar NP, et al
    Malnutrition is associated with diminished baseline and mycobacterial antigen - stimulated chemokine responses in latent tuberculosis infection.
    J Infect. 2018 May 16. pii: S0163-4453(18)30143.
    PubMed     Abstract available


  62. KIM JY, Park JH, Kim MC, Cha HH, et al
    Combined IFN-gamma and TNF-alpha release assay for differentiating active tuberculosis from latent tuberculosis infection.
    J Infect. 2018 May 7. pii: S0163-4453(18)30116.
    PubMed     Abstract available


  63. ZHANG H, Xin H, Li X, Li H, et al
    Reversion of QuantiFERON-TB Gold In-Tube test in individuals with and without prophylactic treatment for latent tuberculosis infection: a Systematic Review and Meta-Analysis.
    J Infect. 2018 May 7. pii: S0163-4453(18)30112.
    PubMed     Abstract available


  64. E BS, Magda E, YuRong Y, Guangyu G, et al
    Identification of a plasma microRNA profile in untreated pulmonary tuberculosis patients that is modulated by anti-mycobacterial therapy.
    J Infect. 2018 May 7. pii: S0163-4453(18)30122.
    PubMed     Abstract available


    April 2018
  65. NGUYEN DTM, Graviss EA
    Development and validation of a prognostic score to predict tuberculosis mortality.
    J Infect. 2018 Apr 9. pii: S0163-4453(18)30062.
    PubMed     Abstract available


    January 2018
  66. XU C, Pang Y, Li R, Ruan Y, et al
    Clinical outcome of multidrug-resistant tuberculosis patients receiving standardized second-line treatment regimen in China.
    J Infect. 2018 Jan 25. pii: S0163-4453(18)30025.
    PubMed     Abstract available


    November 2017
  67. LIU Y, Li X, Liu W, Liu Y, et al
    IL-6 release of Rv0183 antigen-stimulated whole blood is a potential biomarker for active tuberculosis patients.
    J Infect. 2017 Nov 24. pii: S0163-4453(17)30376.
    PubMed     Abstract available


    October 2017
  68. ROYCROFT E, O'Toole RF, Fitzgibbon MM, Montgomery L, et al
    Molecular epidemiology of multi- and extensively-drug-resistant Mycobacterium tuberculosis in Ireland, 2001-2014.
    J Infect. 2017 Oct 12. pii: S0163-4453(17)30315.
    PubMed     Abstract available


    September 2017
  69. FRANCISCO NM, Fang YM, Ding L, Feng S, et al
    Diagnostic accuracy of a selected signature gene set that discriminates active pulmonary tuberculosis and other pulmonary diseases.
    J Infect. 2017 Sep 20. pii: S0163-4453(17)30304.
    PubMed     Abstract available


  70. SHAH R, Nabiswa H, Okinda N, Revathi G, et al
    The Diagnostic Accuracy Of Determine Tb Lam Antigen In Detection Of Extra Pulmonary Tuberculosis (Eptb).
    J Infect. 2017 Sep 4. pii: S0163-4453(17)30268.
    PubMed    


    August 2017
  71. PANG Y, Lu J, Huo F, Ma Y, et al
    Prevalence and treatment outcome of extensively drug-resistant tuberculosis plus additional drug resistance from the National Clinical Center for Tuberculosis in China: a five-year review.
    J Infect. 2017 Aug 10. pii: S0163-4453(17)30262.
    PubMed     Abstract available


  72. TEIXEIRA RC, Rodriguez M, Jimenez de Romero N, Bruins M, et al
    The potential of a portable, point-of-care electronic nose to diagnose tuberculosis.
    J Infect. 2017 Aug 10. pii: S0163-4453(17)30260.
    PubMed     Abstract available


  73. RUFAI SB, Singh A, Singh J, Kumar P, et al
    Diagnostic usefulness of Xpert MTB/RIF assay for detection of tuberculous meningitis using cerebrospinal fluid.
    J Infect. 2017;75:125-131.
    PubMed     Abstract available


    July 2017
  74. VILLAR-HERNANDEZ R, Latorre I, Minguez S, Diaz J, et al
    Use of IFN-gamma and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases.
    J Infect. 2017 Jul 24. pii: S0163-4453(17)30248.
    PubMed     Abstract available


  75. HELLA J, Morrow C, Mhimbira F, Ginsberg S, et al
    Tuberculosis transmission in public locations in Tanzania: a novel approach to studying airborne disease transmission.
    J Infect. 2017 Jul 1. pii: S0163-4453(17)30227.
    PubMed     Abstract available


    June 2017
  76. PEREZ-VELEZ CM, Roya-Pabon CL, Marais BJ
    A systematic approach to diagnosing intra-thoracic tuberculosis in children.
    J Infect. 2017;74 Suppl 1:S74-S83.
    PubMed     Abstract available


  77. OUTHRED AC, Britton PN, Marais BJ
    Drug-Resistant tuberculosis - primary transmission and management.
    J Infect. 2017;74 Suppl 1:S128-S135.
    PubMed     Abstract available


  78. PORMOHAMMAD A, Riahi SM, Nasiri MJ, Fallah F, et al
    Diagnostic test accuracy of adenosine deaminase for tuberculous meningitis: A systematic review and meta-analysis.
    J Infect. 2017;74:545-554.
    PubMed     Abstract available


    May 2017
  79. CLIFFORD V, Tebruegge M, Zufferey C, Germano S, et al
    Mycobacteria-specific cytokine responses as correlates of treatment response in active and latent tuberculosis.
    J Infect. 2017 May 5. pii: S0163-4453(17)30131.
    PubMed     Abstract available


  80. JELJELI M, Guerin-El Khourouj V, Pommelet V, Hormi M, et al
    Cytokine/chemokine secretion for detecting tuberculosis in quantiferon supernatants from HIV+ and HIV- children.
    J Infect. 2017 May 3. pii: S0163-4453(17)30129.
    PubMed    


  81. NOUHIN J, Pean P, Madec Y, Chevalier MF, et al
    Interleukin-1 receptor antagonist, a biomarker of response to anti-TB treatment in HIV/TB co-infected patients.
    J Infect. 2017;74:456-465.
    PubMed     Abstract available


    March 2017
  82. SIMONSEN DF, Farkas DK, Horsburgh CR, Thomsen PR, et al
    Increased risk of active Tuberculosis after Cancer diagnosis.
    J Infect. 2017 Mar 30. pii: S0163-4453(17)30105.
    PubMed    


  83. ARNOLD A, Cooke GS, Kon OM, Dedicoat M, et al
    Drug resistant TB: UK multicentre study (DRUMS): Treatment, management and outcomes in London and West Midlands 2008-2014.
    J Infect. 2017;74:260-271.
    PubMed     Abstract available


    February 2017
  84. PARCELL BJ, Jarchow-MacDonald A, Seagar AL, Laurenson I, et al
    Three Year Evaluation of Xpert MTB/RIF in a Low Prevalence Tuberculosis Setting: a Scottish Perspective.
    J Infect. 2017 Feb 22. pii: S0163-4453(17)30054.
    PubMed     Abstract available


    January 2017
  85. PEGORIE M, Denning DW, Welfare W
    Estimating the burden of invasive and serious fungal disease in the United Kingdom.
    J Infect. 2017;74:60-71.
    PubMed     Abstract available


    December 2016
  86. ZETOLA NM, Modongo C, Matsiri O, Tamuhla T, et al
    Diagnosis of pulmonary tuberculosis and assessment of treatment response through analyses of volatile compound patterns in exhaled breath samples.
    J Infect. 2016 Dec 22. pii: S0163-4453(16)30336.
    PubMed     Abstract available


  87. WYPLOSZ B, Mougari F, Al Rawi M, Baillon C, et al
    Visualizing viable Mycobacterium tuberculosis in sputum to monitor isolation measures.
    J Infect. 2016 Dec 7. pii: S0163-4453(16)30313.
    PubMed    


    November 2016
  88. WON EJ, Choi JH, Cho YN, Jin HM, et al
    Biomarkers for Discrimination between Latent Tuberculosis Infection and Active Tuberculosis Disease.
    J Infect. 2016 Nov 18. pii: S0163-4453(16)30306.
    PubMed     Abstract available


  89. OH J, Choi R, Park HD, Lee H, et al
    Evaluation of vitamin status in patients with pulmonary tuberculosis.
    J Infect. 2016 Nov 10. pii: S0163-4453(16)30280.
    PubMed     Abstract available


    October 2016
  90. KUMAR NP, Moideen K, Sivakumar S, Menon PA, et al
    Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors.
    J Infect. 2016 Oct 4. pii: S0163-4453(16)30246.
    PubMed     Abstract available


    April 2016
  91. PARK KH, Lee MS, Kim SM, Park SJ, et al
    Diagnostic usefulness of T-cell based assays for tuberculous meningitis in HIV-uninfected patients.
    J Infect. 2016;72:486-97.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: